A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

BACKGROUND: There is evidence suggesting that sirolimus, in combination with tacrolimus, is active in the prevention of graft-versus-host disease. Sirolimus-based immune suppression may suppress alloreactive T cells, while sparing the survival and function of regulatory T cells. DESIGN AND METHODS:...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Pidala, Joseph, Kim, Jongphil, Jim, Heather, Kharfan-Dabaja, Mohamed A., Nishihori, Taiga, Fernandez, Hugo F., Tomblyn, Marcie, Perez, Lia, Perkins, Janelle, Xu, Mian, Janssen, William E., Veerapathran, Anandaraman, Betts, Brian C., Locke, Frederick L., Ayala, Ernesto, Field, Teresa, Ochoa, Leonel, Alsina, Melissa, Anasetti, Claudio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ferrata Storti Foundation 2012
Soggetti:
Original Articles and Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3590095/
https://ncbi.nlm.nih.gov/pubmed/22689677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.067140
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi